S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q3 2023

Deep Track Capital

Period: Q3 2023 Β· Filed: 2023-11-14
View on SEC EDGAR β†—
AUM
$2.59B
Total portfolio value
Positions
63
Reported securities
Top Holding
INSM
5.8% $151.5M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
INSMINSMED INC$151.5M5.85%$25.37$111.60+339.9%
5.8%
JAZZJAZZ PHARMACEUTICALS PLC$147.3M5.69%$127.73$243.47+90.6%
5.7%
ITCIINTRA-CELLULAR THERAPIES INC$135.4M5.23%β€”β€”
5.2%
IONSIONIS PHARMACEUTICALS INC$128.6M4.96%$43.43$81.80+88.3%
5.0%
GHGUARDANT HEALTH INC$120.0M4.63%$29.18$167.98+475.7%
4.6%
IMVTIMMUNOVANT INC$107.4M4.15%$34.64$38.79+12.0%
4.2%
ALKSALKERMES PLC$106.4M4.11%$28.07$54.58+94.4%
4.1%
DVAXDYNAVAX TECHNOLOGIES CORP$99.8M3.85%β€”β€”
3.9%
GPCRSTRUCTURE THERAPEUTICS INC$96.5M3.73%$56.60$53.45-5.6%
3.7%
PLRXPLIANT THERAPEUTICS INC$95.4M3.68%$16.05$1.17-92.7%
3.7%
SWTXSPRINGWORKS THERAPEUTICS INC$82.0M3.16%β€”β€”
3.2%
AXSMAXSOME THERAPEUTICS INC$79.7M3.08%$66.85$244.31+265.5%
3.1%
BCYCBICYCLE THERAPEUTICS PLC$70.1M2.71%$19.93$4.35-78.2%
2.7%
TVTXTRAVERE THERAPEUTICS INC$65.9M2.54%$8.42$56.92+576.0%
2.5%
NTLAINTELLIA THERAPEUTICS INC$63.2M2.44%$29.41$17.56-40.3%
2.4%
EDITEDITAS MEDICINE INC$55.4M2.14%$7.14$3.65-48.9%
2.1%
GERNGERON CORP$54.5M2.10%$1.99$1.36-31.7%
2.1%
VRNAVERONA PHARMA PLC$52.0M2.01%β€”β€”
2.0%
APGEAPOGEE THERAPEUTICS INC$51.4M1.98%$20.40$132.91+551.5%
2.0%
PACBPACIFIC BIOSCIENCES CALIF IN$50.1M1.93%$8.05$1.68-79.1%
1.9%
VRDNVIRIDIAN THERAPEUTICS INC$45.5M1.75%$14.60$19.40+32.9%
1.8%
NVCRNOVOCURE LTD$40.4M1.56%$15.59$17.20+10.3%
1.6%
HLVXHILLEVAX INC$39.0M1.51%β€”β€”
1.5%
RPTXREPARE THERAPEUTICS INC$37.1M1.43%β€”β€”
1.4%
AGENAGENUS INC$35.8M1.38%$21.00$3.49-83.4%
1.4%
FDMT4D MOLECULAR THERAPEUTICS IN$35.4M1.37%$11.81$13.00+10.1%
1.4%
AUTLAUTOLUS THERAPEUTICS PLC$35.0M1.35%$2.18$1.58-27.5%
1.4%
NBIXNEUROCRINE BIOSCIENCES INC$33.8M1.30%$111.79$174.26+55.9%
1.3%
TERNTERNS PHARMACEUTICALS INC$30.2M1.16%$4.91β€”
1.2%
RAPTRAPT THERAPEUTICS INC$24.9M0.96%β€”β€”
1.0%

Quarter-on-Quarter Activity

Q3 2023 vs. Q2 2023

New Positions (8)

TickerIssuerNotionalSince Filing
APGEAPOGEE THERAPEUTICS INC$51.4M+551.5%
NVCRNOVOCURE LTD$40.4M+10.3%
HLVXHILLEVAX INC$39.0M
NBIXNEUROCRINE BIOSCIENCES INC$33.8M+55.9%
ANABANAPTYSBIO INC$24.2M
OLMAOLEMA PHARMACEUTICALS INC$23.9M
AMLXAMYLYX PHARMACEUTICALS INC$23.1M
BNTXBIONTECH SE$21.7M

Exited Positions (8)

TickerIssuerNotional
ORTXORCHARD THERAPEUTICS PLC$10.6M
INZYINOZYME PHARMA INC$9.2M
ZNTLZENTALIS PHARMACEUTICALS INC$8.5M
MLTXMOONLAKE IMMUNOTHERAPEUTICS$5.5M
FGENFIBROGEN INC$2.1M
ALLKALLAKOS INC$1.0M
IMUXIMMUNIC INC$0.8M
INKTXXXXMINK THERAPEUTICS INC$0.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
TERNTERNS PHARMACEUTICALS INC$20.6M+445.9%
PACBPACIFIC BIOSCIENCES CALIF IN$30.8M+313.5%-79.1%
AXSMAXSOME THERAPEUTICS INC$52.1M+196.9%+265.5%
GHGUARDANT HEALTH INC$66.3M+170.0%+475.7%
NTLAINTELLIA THERAPEUTICS INC$29.2M+139.4%-40.3%
VRDNVIRIDIAN THERAPEUTICS INC$15.0M+131.6%+32.9%
MORFMORPHIC HLDG INC$-1.6M+117.1%
EDITEDITAS MEDICINE INC$27.0M+105.6%-48.9%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ETNB89BIO INC$-8.1M-81.9%
CMPSCOMPASS PATHWAYS PLC$-3.2M-51.6%
IMVTIMMUNOVANT INC$4.6M-48.4%+12.0%
IPSCCENTURY THERAPEUTICS INC$-2.1M-46.9%
ATXSASTRIA THERAPEUTICS INC$-6.4M-38.9%
ABOSACUMEN PHARMACEUTICALS INC$-8.4M-35.8%
GPCRSTRUCTURE THERAPEUTICS INC$-13.5M-27.6%-5.6%
BEAMBEAM THERAPEUTICS INC$-17.6M-22.9%
← Back to Hedge Funds